IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.524
AS - Asia 1.689
EU - Europa 928
SA - Sud America 248
AF - Africa 226
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.449
SG - Singapore 875
CN - Cina 465
IT - Italia 325
BR - Brasile 204
IE - Irlanda 191
CI - Costa d'Avorio 147
VN - Vietnam 108
RU - Federazione Russa 94
KR - Corea 85
DE - Germania 71
GB - Regno Unito 49
UA - Ucraina 49
CA - Canada 48
IN - India 40
NL - Olanda 35
SN - Senegal 25
BJ - Benin 22
FI - Finlandia 22
HK - Hong Kong 22
JP - Giappone 19
MX - Messico 19
PL - Polonia 19
AR - Argentina 17
CZ - Repubblica Ceca 16
BD - Bangladesh 14
NG - Nigeria 14
SE - Svezia 13
ID - Indonesia 12
ES - Italia 11
ZA - Sudafrica 11
FR - Francia 9
TR - Turchia 9
CH - Svizzera 8
IQ - Iraq 8
CO - Colombia 6
PE - Perù 6
EC - Ecuador 5
PY - Paraguay 5
IR - Iran 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MA - Marocco 3
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
PK - Pakistan 1
QA - Qatar 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
Totale 5.619
Salva come PNG Salva come JPEG
Città #
Singapore 503
Santa Clara 471
Dallas 418
Dublin 191
Chandler 179
Hefei 170
Ashburn 166
Abidjan 147
Los Angeles 143
Chicago 108
Seoul 84
Beijing 76
Boardman 69
Civitanova Marche 65
Cambridge 50
Jacksonville 50
Lawrence 50
New York 49
Catania 48
Ho Chi Minh City 41
Moscow 39
Andover 38
Buffalo 37
Nanjing 28
Bremen 26
Amsterdam 25
Dakar 25
São Paulo 25
Des Moines 24
Cotonou 22
Hong Kong 21
Tokyo 19
Hanoi 18
Toronto 18
Lappeenranta 17
Milan 17
Saint Petersburg 17
Warsaw 17
Brooklyn 16
Denver 16
Wilmington 15
Abuja 14
Brno 13
Chennai 13
Poplar 13
Rome 13
San Francisco 12
Stockholm 12
Council Bluffs 11
Washington 11
Houston 10
Nanchang 9
Orem 9
Phoenix 9
Haiphong 8
Mexico City 8
Montreal 8
Ankara 7
Atlanta 7
Manchester 7
Frankfurt am Main 6
Johannesburg 6
London 6
Redwood City 6
Rio de Janeiro 6
Shenyang 6
Arequipa 5
Calgary 5
Genoa 5
Hebei 5
Messina 5
Mumbai 5
Munich 5
Palermo 5
Querétaro 5
Redondo Beach 5
San Mateo 5
Tianjin 5
Turin 5
Turku 5
Baghdad 4
Bernareggio 4
Bắc Ninh 4
Changsha 4
Columbus 4
Da Nang 4
Dhaka 4
Dong Ket 4
Misterbianco 4
Pune 4
Tehran 4
The Dalles 4
Bari 3
Bishkek 3
Boston 3
Brussels 3
Charlotte 3
Curitiba 3
Falls Church 3
Favara 3
Totale 3.930
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 99
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 95
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 93
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 92
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 92
Minor pulmonary malformations in a child 91
Lung clearance index: A new measure of late lung complications of cancer therapy in children 91
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 91
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 89
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 89
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 88
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 87
Serum YKL-40 in children with asthma 87
Lactoferrin: Cytokine modulation and application in clinical practice 87
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 87
Hypertransaminasemia in children is not always as simple as it seems 86
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 85
Biomarkers in pediatric lung diseases including cystic fibrosis 85
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 83
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 83
Cetirizine use in childhood: An update of a friendly 30-year drug 82
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 81
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 80
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 78
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 78
HMGB1 values and response to HBV vaccine in children with celiac disease 77
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 76
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 75
Exhaled breath temperature in astmatic children 74
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 74
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 74
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 73
Antihistamines: ABC for the pediatricians 73
Novel therapeutic targets for allergic airway disease in children 72
Liver disease in Cystic Fibrosis: an update 71
Antihistamines in children and adolescents: A practical update 70
Severe Kawasaki disease in a 3-month-old patient: a case report. 69
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 68
Severe disease in Cystic Fibrosis and fecal calprotectin levels 67
Genetic disorders of surfactant deficiency and neonatal lung disease 67
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 65
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 64
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 64
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 64
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 64
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 63
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 63
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 62
Lung clearance index for evaluation of late complications of cancer therapy in children 62
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 60
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 59
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 59
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 58
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 58
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 58
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 57
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 57
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 56
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 56
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 55
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 55
The immunomodulatory role of vitamin D in respiratory diseases 54
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 53
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 53
Lower airway microbiota 53
Upper and lower airways diseases in childhood 51
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 49
Type 2 inflammation in cystic fibrosis: New insights 49
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 48
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 47
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 47
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 46
Protracted bacterial bronchitis: more to know 45
Nasal microbiome in chronic rhinosinusitis 43
The role of skin infections in atopic dermatitis in children 42
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells 42
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 41
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 35
Pidotimod in allergic diseases 33
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management 27
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 20
Oral immunotherapy in children with allergic diseases: past, present and future 19
HMGB1 as a Biomarker of Inhaled Corticosteroid Treatment Response in Moderate-Severe Asthmatic Children: A Single Center Pilot Study 19
Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis 17
Reply to Schriever et al. 16
Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators 16
Efficacy of sublingual allergen-specific immunotherapy in children evaluated by the measurements of bronchial and nasal nitric oxide. Preliminary results 16
Calprotectin in cystic fibrosis: A new marker of flogosis 12
Effectiveness of omalizumab in two children with severe vernal keratoconjunctivitis 11
Novel biologics for the treatment of pediatric severe asthma 11
Correlation between RINT values and echocardiographic indices in pre-school children with chronic cough and wheezing 11
Three Consecutive Cases of Double Aortic Arch with Various Clinical Onset 11
Influence of early growth on childhood lung function assessed by magnetic resolution imaging and spirometry. The Generation R Study 11
Serum levels of YKL-40 in patients with cystic fibrosis: A pilot study 11
Efficacy and Safety of Pidotimod in Childhood Wheezing: A Pilot Study 10
Plasmatic Amino Acids in Patients with Cystic Fibrosis: An Observational Study 10
Measurement of nitric oxide and assessment of airway diseases in children: An update 10
Extreme hyperferritinemia in the pediatric emergency setting: haemophagocytic lymphohistiocytosis, macrophage activation syndrome, sepsis and more 10
COVID-19, anosmia, and ageusia in atopic children 10
COVID-19 ocular manifestation in children 10
Totale 5.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 39 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.625 47 188 68 112 292 310 48 33 75 148 163 141
2025/20262.504 265 330 595 366 948 0 0 0 0 0 0 0
Totale 5.790